The Quality Of Life of Patients with Chronic Kidney Disease who Undergo Hemodialysis in RSUD Cilacap

Arik Dian Eka Pratiwi; Maria Immaculata Iwo; Murwiningsih Murwiningsih

doi:10.36858/jkds.v13i1.839

Authors

Arik Dian Eka Pratiwi Sekolah Tinggi Ilmu Farmasi Yayasan Pharmasi Semarang
Maria Immaculata Iwo Program Studi Magister Farmasi, Sekolah Farmasi, Institut Teknologi Bandung
Murwiningsih Murwiningsih 2Rumah Sakit Umum Daerah Cilacap

DOI:

https://doi.org/10.36858/jkds.v13i1.839

Keywords:

quality of life, chronic kidney disease, hemodialysis

Abstract

Chronic Kidney Disease (CKD) is one of the mayor health problems in the worldwide. The incidence of CKD continously increase every year, including in Indonesia. Hemodialysis (HD) is the most widely used process of kidney function replacement in Indonesia, including in RSUD Cilacap. This research aim is to study the quality of life (QoL) of CKD patients undergo hemodialysis in RSUD Cilacap using analytic observational design with cross sectional approach. The sampling was carried out using purposive sampling technique. The quality of life of patients was assessed based on WHOQoL-BREF questionnaire consisting of 4 domains i.e., physical, psychological, social relationships, and environment. Other aspects i.e., the CKD causes and therapy adherence were also analyzed. This research employs a descriptive design. The study conducted was univariate to ascertain the distribution of respondent characteristics, which was utilized to evaluate the variance in the quality of life domain among haemodialysis patients. Result showed that hypertension was the main causes of CKD at RSUD Cilacap (59%) beside diabetic mellitus (17%). Before HD, the blood pressure of all patients were in stage 1 hypertension condition with systole: 148.67±29.24 mmHg and dyastole: 80.10±5.47 mmHg. Result of WHOQoL-BREF questionnaire analyses, showed that none of the four domains meet the criteria of good QoL. Generally, based on this data, it can be said that the QoL of CKD patients at RSUD Cilacap were poor categories with score for all domains and a total score (48.96±7.95) below the normal rate. Therapy of hypertension condition of patients before HD with furosemide alone, furosemide+clonidine, and or furosemide+valsartan, could maintain the blood pressure of patients in target value i.e, <140/90 mmHg. Based on those data, it can be concluded that compliance of the patients are important in the improving of QoL of CKD patients who undergo HD in RSUD Cilacap..

References

Alfonso, A. A., Mongan, A. E., & Memah, M. F. (2016). Gambaran kadar kreatinin serum pada pasien penyakit ginjal kronik stadium 5 non dialisis . EBiomedik, 4(1), 178–183.

Badan Penelitian dan Pengembangan Kementerian Kesehatan RI. (2013). Riset Kesehatan Dasar (Riskerdas) 2013.

Bello, A. K., Okpechi, I. G., Osman, M. A., Cho, Y., Htay, H., Jha, V., Wainstein, M., & Johnson, D. W. (2022). Epidemiology of haemodialysis outcomes. Nature Reviews Nephrology, 18(6), 378–395. https://doi.org/10.1038/s41581-022-00542-7

Cavill, I. (2002). Iron and erythropoietin in renal disease. Nephrology Dialysis Transplantation, 17(90005), 19–23. https://doi.org/10.1093/ndt/17.suppl_5.19

Chen, T. K., Knicely, D. H., & Grams, M. E. (2019). Chronic Kidney Disease Diagnosis and Management. JAMA, 322(13), 1294. https://doi.org/10.1001/jama.2019.14745

I. NKF-K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: Update 2000. (2001). American Journal of Kidney Diseases, 37(1), S7–S64. https://doi.org/10.1016/S0272-6386(01)70005-4

Inrig, J. K., Patel, U. D., Toto, R. D., & Szczech, L. A. (2009). Association of Blood Pressure Increases During Hemodialysis With 2-Year Mortality in Incident Hemodialysis Patients: A Secondary Analysis of the Dialysis Morbidity and Mortality Wave 2 Study. American Journal of Kidney Diseases, 54(5), 881–890. https://doi.org/10.1053/j.ajkd.2009.05.012

Kumra, R., & Bargman, J. M. (2014). A review of diuretic use in dialysis patients. Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis, 30, 115–119.

Liu, Y. (2006). Renal fibrosis: New insights into the pathogenesis and therapeutics. Kidney International, 69(2), 213–217. https://doi.org/10.1038/sj.ki.5000054

Lv, J., Perkovic, V., Foote, C. V, Craig, M. E., Craig, J. C., & Strippoli, G. F. M. (2012). Antihypertensive agents for preventing diabetic kidney disease. The Cochrane Database of Systematic Reviews, 12(12), CD004136. https://doi.org/10.1002/14651858.CD004136.pub3

Muhammad, A., & Sianipar, O. (2018). Penentuan Defisiensi Besi Anemia Penyakit Kronis Menggunakan Peran Indeks sTfR-F. Indonesian Journal Of Clinical Pathology And Medical Laboratory, 12(1), 9–15. https://doi.org/10.24293/ijcpml.v12i1.833

National Kidney Foundation. (2005). K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. American Journal of Kidney Diseases, 45, 16–153.

Ndahayo, D., Bimenyimana Gapira, E., Mbabazi, T., & Chironda, G. (2021). Factors associated with hemodialysis adequacy among end stage renal disease patients on maintenance hemodialysis in Rwanda. International Journal of Advanced Nursing Studies, 10(1), 9–18. https://doi.org/10.14419/ijans.v10i1.31454

Nurhayati, E., Kamilla, L., & Lestari, C. V. B. (2023). Analisis Kadar Ureum Dan Kreatinin Pada Pasien Hipertensi Dengan Gagal Ginjal Kronik Yang Menjalani Terapi Hemodialisa di RSUD dr Abdul Aziz. Jurnal Laboratorium Khatulistiwa, 7(1), 70–77.

Pernefri. (2003). Konsensus Dialisis Perhimpunan Nefrologi Indonesia.

Pernefri. (2015). 8th Report of Indonesian Renal Registry.

Sathvik, B., Parthasarathi, G., Narahari, M., & Gurudev, K. (2008). An assessment of the quality of life in hemodialysis patients using the WHOQOL-BREF questionnaire. Indian Journal of Nephrology, 18(4), 141. https://doi.org/10.4103/0971-4065.45288

Septiwi, C., Yetti, K., & Gayatri, D. (2011). Hubungan Antara Adekuasi Hemodialisis terhadap Kualitas Hidup Pasien Hemodialisis di Unit Hemodialisis RS Prof. Dr. Margono Soekarjo Purwokerto. MajalahKeperawatanUnpad, 13(1).

Silva, P. A. B., Soares, S. M., Santos, J. F. G., & Silva, L. B. (2014). Cut-off point for WHOQOL-bref as a measure of quality of life of older adults. Revista de Saúde Pública, 48(3), 390–397. https://doi.org/10.1590/S0034-8910.2014048004912

Smeltzer, & Bare. (2002). Keperawatan Medikal Bedah. EGC.

Syamsiah, N., & Ratna, S. (2011). Faktor-faktor yang berhubungan dengan kepatuhan pasien CKD yang menjalani hemodialisa di RSPAU dr. Esnawan Antariksa Halim Perdana Kusuma Jakarta . Universitas Indonesia.

Tepel, M., Hopfenmueller, W., Scholze, A., Maier, A., & Zidek, W. (2008). Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients. Nephrology Dialysis Transplantation, 23(11), 3605–3612. https://doi.org/10.1093/ndt/gfn304

Van Wyck, D. B. (2000). Management of early renal anaemia: diagnostic work‐up, iron therapy, epoetin therapy. Nephrology Dialysis Transplantation, 15(suppl_3), 36–39. https://doi.org/10.1093/oxfordjournals.ndt.a027975

Koss W. (1998). Anemias of abnormal iron Metabolism and hemochromatosis. In: Koepke JA, Martin EA, Steininger CA eds. Clinical Haematology, Principles Procedures and Correlation (9th ed.). Lippincot.

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., MacLaughlin, E. J., Muntner, P., Ovbiagele, B., Smith, S. C., Spencer, C. C., Stafford, R. S., Taler, S. J., Thomas, R. J., Williams, K. A., … Wright, J. T. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension, 71(6), 1269–1324. https://doi.org/10.1161/HYP.0000000000000066

WHO. (1993). QualityofLifeBREF.